Due to the prevalence of cardiovascular diseases, there is a large need for small diameter
vascular grafts that cannot be fulfilled using autologous vessels. Although medium to large …

When blood first encounters the artificial surface of a medical device, a complex series of
biochemical reactions is triggered, potentially resulting in clinical complications such as …

Functional remodeling and prolonged anti-inflammatory responses are both vital for
repairing damage in the cardiovascular system. Although these aspects have each been …

Device-associated clot formation and poor tissue integration are ongoing problems with
permanent and temporary implantable medical devices. These complications lead to …

Vascular regeneration and patency maintenance, without anticoagulant administration,
represent key developmental trends to enhance small-diameter vascular grafts (SDVG) …

Fabricating a biocompatible small-diameter vascular graft (< 6 mm) with mechanical
properties similar to the natural vein and adding good anti-thrombogenic, endothelialization …

Due to poor vessel quality in patients with cardiovascular diseases, there has been an
increased demand for small-diameter tissue-engineered blood vessels that can be used as …

Rapid endothelialization of small-diameter vascular grafts remains a significant challenge in
clinical practice. In addition, compliance mismatch causes intimal hyperplasia and finally …

Cardiovascular implants, especially vascular grafts made of synthetic polymers, find wide
clinical applications in the treatment of cardiovascular diseases. However, cases of failure …

Small-diameter artificial vascular grafts (SDAVG) are used to bypass blood flow in arterial
occlusive diseases such as coronary heart or peripheral arterial disease. However, SDAVGs …